Status:
UNKNOWN
Accuracy of CGM in the ICU, Compared to Standard of Care
Lead Sponsor:
University of British Columbia
Collaborating Sponsors:
DexCom, Inc.
Conditions:
Diabetes
Eligibility:
All Genders
18+ years
Brief Summary
To determine the performance of the Dexcom CGM device in comparison to arterial glucose samples.
Detailed Description
The performance of the Dexcom continuous glucose sensor will be compared with the current standard of care which is arterial glucose samples analyzed on a glucose meter. Subjects will be ICU patients ...
Eligibility Criteria
Inclusion
- minimum age 18 years
- anticipated to be on an insulin infusion for 3-7 consecutive days
- 10 of these subjects will be on vasopressors who will be receiving large volume fluid resuscitation
Exclusion
- subjects not on insulin infusion
Key Trial Info
Start Date :
November 6 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04352907
Start Date
November 6 2020
End Date
September 1 2022
Last Update
June 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vancouver General Hospital
Vancouver, British Columbia, Canada, V5Z 1M9